Latest Breaking News On - Acumen pharmaceuticals inc - Page 8 : comparemela.com

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totalling 699,400 shares, a growth of 53.6% from the December 31st total of 455,200 shares. Approximately 1.8% of the company’s stock are short sold. Based on an […]

United statesDaniel joseph oconnellDerekm meisnerAmerican international group incNews ratings for acumen pharmaceuticals dailyAcumen pharmaceuticals incAcumen pharmaceuticalsAcumen pharmaceuticals company profileSecurities exchange commissionChicago partners investment groupDeutsche bank aktiengesellschaftAcumen pharmaceuticals stock downGet free reportPharmaceuticals stock downExchange commissionJoseph oconnell